Literature DB >> 23350853

A KCNQ1 mutation causes a high penetrance for familial atrial fibrillation.

Daniel C Bartos1, Jeffrey B Anderson, Rachel Bastiaenen, Jonathan N Johnson, Michael H Gollob, David J Tester, Don E Burgess, Tessa Homfray, Elijah R Behr, Michael J Ackerman, Pascale Guicheney, Brian P Delisle.   

Abstract

BACKGROUND: Atrial fibrillation (AF) is the most common cardiac arrhythmia, and its incidence is expected to grow. A genetic predisposition for AF has long been recognized, but its manifestation in these patients likely involves a combination of rare and common genetic variants. Identifying genetic variants that associate with a high penetrance for AF would represent a significant breakthrough for understanding the mechanisms that associate with disease. METHOD AND
RESULTS: Candidate gene sequencing in 5 unrelated families with familial AF identified the KCNQ1 missense mutation p.Arg231His (R231H). In addition to AF, several of the family members have abnormal QTc intervals, syncope or experienced sudden cardiac arrest or death. KCNQ1 encodes the voltage-gated K(+) channel that conducts the slowly activating delayed rectifier K(+) current in the heart. Functional and computational analyses suggested that R231H increases KCNQ1 current (I(KCNQ1)) to shorten the atrial action potential (AP) duration. R231H is predicted to minimally affect ventricular excitability, but it prevented the increase in I(KCNQ1) following PKA activation. The unique properties of R231H appeared to be caused by a loss in voltage-dependent gating.
CONCLUSIONS: The R231H variant causes a high penetrance for interfamilial early-onset AF. Our study indicates R231H likely shortens atrial refractoriness to promote a substrate for reentry. Additionally, R231H might cause abnormal ventricular repolarization by disrupting PKA activation of IKCNQ1 . We conclude genetic variants, which increase IKs during the atrial AP, decrease the atrial AP duration, and/or shorten atrial refractoriness, present a high risk for interfamilial AF.
© 2012 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23350853      PMCID: PMC3640728          DOI: 10.1111/jce.12068

Source DB:  PubMed          Journal:  J Cardiovasc Electrophysiol        ISSN: 1045-3873


  39 in total

Review 1.  Therapeutic strategies for long-QT syndrome: does the molecular substrate matter?

Authors:  Yanfei Ruan; Nian Liu; Carlo Napolitano; Silvia G Priori
Journal:  Circ Arrhythm Electrophysiol       Date:  2008-10

2.  KCNQ1 mutation Q147R is associated with atrial fibrillation and prolonged QT interval.

Authors:  Alicia Lundby; Lasse Steen Ravn; Jesper Hastrup Svendsen; Søren-Peter Olesen; Nicole Schmitt
Journal:  Heart Rhythm       Date:  2007-08-01       Impact factor: 6.343

3.  De novo KCNQ1 mutation responsible for atrial fibrillation and short QT syndrome in utero.

Authors:  Kui Hong; David R Piper; Aurora Diaz-Valdecantos; Josep Brugada; Antonio Oliva; Elena Burashnikov; José Santos-de-Soto; Josefina Grueso-Montero; Ernesto Diaz-Enfante; Pedro Brugada; Frank Sachse; Michael C Sanguinetti; Ramon Brugada
Journal:  Cardiovasc Res       Date:  2005-08-18       Impact factor: 10.787

4.  Prevalence of early-onset atrial fibrillation in congenital long QT syndrome.

Authors:  Jonathan N Johnson; David J Tester; James Perry; Benjamin A Salisbury; Carol R Reed; Michael J Ackerman
Journal:  Heart Rhythm       Date:  2008-02-08       Impact factor: 6.343

5.  Mutation in the S3 segment of KCNQ1 results in familial lone atrial fibrillation.

Authors:  Saumya Das; Seiko Makino; Yonathan F Melman; Marisa A Shea; Sanjeev B Goyal; Anthony Rosenzweig; Calum A Macrae; Patrick T Ellinor
Journal:  Heart Rhythm       Date:  2009-04-15       Impact factor: 6.343

Review 6.  Status of the epidemiology of atrial fibrillation.

Authors:  William B Kannel; Emelia J Benjamin
Journal:  Med Clin North Am       Date:  2008-01       Impact factor: 5.456

7.  Augmented potassium current is a shared phenotype for two genetic defects associated with familial atrial fibrillation.

Authors:  Robert L Abraham; Tao Yang; Marcia Blair; Dan M Roden; Dawood Darbar
Journal:  J Mol Cell Cardiol       Date:  2009-07-30       Impact factor: 5.000

8.  Novel KCNE3 mutation reduces repolarizing potassium current and associated with long QT syndrome.

Authors:  Seiko Ohno; Futoshi Toyoda; Dimitar P Zankov; Hidetada Yoshida; Takeru Makiyama; Keiko Tsuji; Toshihiro Honda; Kazuhiko Obayashi; Hisao Ueyama; Wataru Shimizu; Yoshihiro Miyamoto; Shiro Kamakura; Hiroshi Matsuura; Toru Kita; Minoru Horie
Journal:  Hum Mutat       Date:  2009-04       Impact factor: 4.878

9.  Mutations in the potassium channel subunit KCNE1 are associated with early-onset familial atrial fibrillation.

Authors:  Morten S Olesen; Bo H Bentzen; Jonas B Nielsen; Annette B Steffensen; Jens-Peter David; Javad Jabbari; Henrik K Jensen; Stig Haunsø; Jesper H Svendsen; Nicole Schmitt
Journal:  BMC Med Genet       Date:  2012-04-03       Impact factor: 2.103

10.  KCNE peptides differently affect voltage sensor equilibrium and equilibration rates in KCNQ1 K+ channels.

Authors:  Jessica M Rocheleau; William R Kobertz
Journal:  J Gen Physiol       Date:  2007-12-17       Impact factor: 4.086

View more
  25 in total

Review 1.  Genetic testing for inherited cardiac disease.

Authors:  Arthur A M Wilde; Elijah R Behr
Journal:  Nat Rev Cardiol       Date:  2013-07-30       Impact factor: 32.419

Review 2.  Emerging directions in the genetics of atrial fibrillation.

Authors:  Nathan R Tucker; Patrick T Ellinor
Journal:  Circ Res       Date:  2014-04-25       Impact factor: 17.367

Review 3.  Ion Channels in the Heart.

Authors:  Daniel C Bartos; Eleonora Grandi; Crystal M Ripplinger
Journal:  Compr Physiol       Date:  2015-07-01       Impact factor: 9.090

4.  Functional testing for variant prioritization in a family with long QT syndrome.

Authors:  Maliheh Najari Beidokhti; Alexander C Bertalovitz; Weizhen Ji; Jorge McCormack; Lauren Jeffries; Emily Sempou; Mustafa K Khokha; Thomas V McDonald; Saquib A Lakhani
Journal:  Mol Genet Genomics       Date:  2021-04-19       Impact factor: 3.291

Review 5.  The Role of Pharmacogenetics in Atrial Fibrillation Therapeutics: Is Personalized Therapy in Sight?

Authors:  Dawood Darbar
Journal:  J Cardiovasc Pharmacol       Date:  2016-01       Impact factor: 3.105

Review 6.  Genetics of atrial fibrillation: from families to genomes.

Authors:  Ingrid E Christophersen; Patrick T Ellinor
Journal:  J Hum Genet       Date:  2015-05-21       Impact factor: 3.172

Review 7.  Cardiac Delayed Rectifier Potassium Channels in Health and Disease.

Authors:  Lei Chen; Kevin J Sampson; Robert S Kass
Journal:  Card Electrophysiol Clin       Date:  2016-04-01

Review 8.  Atrial fibrillation: the role of common and rare genetic variants.

Authors:  Morten S Olesen; Morten W Nielsen; Stig Haunsø; Jesper H Svendsen
Journal:  Eur J Hum Genet       Date:  2013-07-10       Impact factor: 4.246

Review 9.  Genetic mechanisms of atrial fibrillation: impact on response to treatment.

Authors:  Dawood Darbar; Dan M Roden
Journal:  Nat Rev Cardiol       Date:  2013-04-16       Impact factor: 32.419

10.  A KCNQ1 mutation causes age-dependant bradycardia and persistent atrial fibrillation.

Authors:  Chang-Seok Ki; Chae Lim Jung; Hyun-ji Kim; Kwan-Hyuck Baek; Seung Jung Park; Young Keun On; Ki-Suk Kim; Su Jin Noh; Jae Boum Youm; June Soo Kim; Hana Cho
Journal:  Pflugers Arch       Date:  2013-08-30       Impact factor: 3.657

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.